Showing results (311-320 of 372) with videos related to

Sort By:
Pageof 38
Oncogenesis|February 12, 2019
Most canine ameloblastomas harbor HRAS mutations, providing a novel large-animal model of RAS-driven cancerPersiana S Saffari, Natalia Vapniarsky, Anna S Pollack, et al.
Plos One|September 3, 2011
SMURF1 amplification promotes invasiveness in pancreatic cancerKevin A Kwei, A Hunter Shain, Ryan Bair, et al.
The American Journal of Pathology|February 25, 2003
Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarrayJohn P T Higgins, Rajesh Shinghal, Harcharan Gill, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2002
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumorsJonathan R Pollack, Therese Sørlie, Charles M Perou, et al.
The Journal of Trauma and Acute Care Surgery|January 9, 2023
Long-term health-related quality of life and independence among older survivors of serious injuryLauren R Pollack, Joanna Liao, Elisabeth B Powelson, et al.
The American Journal of Surgical Pathology|January 3, 2020
Gene Expression Profiling of Head and Neck Tumors Identifies FOXP1 and SOX10 Expression as Useful for Distinguishing Ameloblastoma From Basaloid Salivary Gland TumorsYen Chen Kevin Ko, Sushama Varma, Chun Fang Zhu, et al.
Acta Scientific Neurology|March 30, 2026
Hypothesizing Enhanced Brain Activity as A Function of Dopamine Homeostasis as Observed with KB220 in A Male with Delayed Cognitive PerformanceFrans J Cronje, Ronald Swatzyna, Igor Elman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2012
CDX2 is an amplified lineage-survival oncogene in colorectal cancerKeyan Salari, Mary E Spulak, Justin Cuff, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2022
Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domainHannah C Feldman, Elisa Merlini, Carlos Guijas, et al.
Haematologica|December 2, 2021
The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangementsSarah Grasedieck, Ariene Cabantog, Liam MacPhee, et al.
Pageof 38